Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2
Sponsor: Erbe USA Incorporated
Listed as NCT03638843, this NA trial focuses on Bariatric Surgery Candidate and Obesity and remains completed. Sponsored by Erbe USA Incorporated, it has been updated 15 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
-
Mar 2021 — Sep 2021 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Mar 2021 [monthly]
Enrolling By Invitation NA
▶ Show 10 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Oct 2020 — Nov 2020 [monthly]
Not Yet Recruiting NA
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting NA
-
Jul 2020 — Sep 2020 [monthly]
Not Yet Recruiting NA
-
May 2020 — Jul 2020 [monthly]
Not Yet Recruiting NA
-
Mar 2020 — May 2020 [monthly]
Not Yet Recruiting NA
-
Oct 2019 — Mar 2020 [monthly]
Not Yet Recruiting NA
-
Feb 2019 — Oct 2019 [monthly]
Not Yet Recruiting NA
-
Nov 2018 — Feb 2019 [monthly]
Not Yet Recruiting NA
-
Sep 2018 — Nov 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Erbe USA Incorporated
- Johns Hopkins University
For direct contact, visit the study record on ClinicalTrials.gov .